The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Open accessAbstract
Post-mortem analyses of brains from patients with Parkinson disease who received fetal mesencephalic transplants show that α-synuclein-containing (α-syn-containing) Lewy bodies gradually appear in grafted neurons. Here, we explored whether intercellular transfer of α-syn from host to graft, followed by seeding of α-syn aggregation in recipient neurons, can contribute to this phenomenon. We assessed α-syn cell-to-cell transfer using microscopy, flow cytometry, and high-content screening in several coculture model systems. Coculturing cells engineered to express either GFP- or DsRed-tagged α-syn resulted in a gradual increase in double-labeled cells. Importantly, α-syn-GFP derived from 1 neuroblastoma cell line localized to red fluorescent aggregates in other cells expressing DsRed-α-syn, suggesting a seeding effect of transmitted α-syn. Extracellular α-syn was taken up by cells through endocytosis and interacted with intracellular α-syn. Next, following intracortical injection of recombinant α-syn in rats, we found neuronal uptake was attenuated by coinjection of an endocytosis inhibitor. Finally, we demonstrated in vivo transfer of α-syn between host cells and grafted dopaminergic neurons in mice overexpressing human α-syn. In summary, intercellularly transferred α-syn interacts with cytoplasmic α-syn and can propagate α-syn pathology. These results suggest that α-syn propagation is a key element in the progression of Parkinson disease pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Particularly, the oligomeric α-Syn species appear to be prone to uptake and spread from cell-to-cell in a prion-like manner, leading to the templated misfolding of the native forms of α-Syn and formation of α-Syn aggregates throughout the brain, which are the defining pathological features of Parkinson’s disease (PD) and dementia with Lewy body (DLB) [12–19].”
From LRP1 is a neuronal receptor for α-synuclein uptake and spread (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredIn the citing paper
“In cell culture, however, the prion-like propagation of α-synuclein lesions has been demonstrated80, 81”
From Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders (2011) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,904
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citationTransmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 834
Ensemencement et propagation des lésions dans les maladies neurodégénératives: un nouveau paradigme
Duyckaerts, C. J., Seilhean, D., Sazdovitch, V., Plu, I., Delatour, B., & Potier, M. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30883-0 · Cited by 12
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation
Galzitskaya, O. V., Grishin, S. Y., Glyakina, A. V., Dovidchenko, N. V., Konstantinova, A. V., Kravchenko, S. V., & Surin, A. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043781 · Cited by 12
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13
The gut-brain axis in the pathogenesis of Parkinson’s disease
Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12
von Einem, B., Eschbach, J., Kiechle, M., Wahler, A., Thal, D. R., McLean, P. J., Weishaupt, J. H., Ludolph, A. C., Arnim, C. A. F. V., & Danzer, K. M. (2017) · Aging · doi:10.18632/aging.101261 · Cited by 12
Raj, A., Kaushal, A., & Datta, I. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24994 · Cited by 11
Toxicity of internalized polyalanine to cells depends on aggregation
Iizuka, Y., Owada, R., Kawasaki, T., Hayashi, F., Sonoyama, M., & Nakamura, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02889-6 · Cited by 11
Courte, J., Le, N. A., Pan, T., Bousset, L., Melki, R., Villard, C., & Peyrin, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04915-4 · Cited by 11
Self-citationCouldα-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?
Busquets, M. A., Espargaró, A., Estelrich, J., & Sabaté, R. (2015) · BioMed Research International · doi:10.1155/2015/172018 · Cited by 11
Christmann, A., Gries, M., Scholz, P., Stahr, P. L., Law, J. K. Y., Schulte, S., Martin, M., Lilischkis, R., Ingebrandt, S., Keck, C. M., et al. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0259 · Cited by 11
Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
Wang, X., Noroozian, Z., Lynch, M., Armstrong, N., Schneider, R., Liu, M., Ghodrati, F., Zhang, A. B., Yang, Y. J., Hall, A. C., et al. (2017) · Discoveries · doi:10.15190/d.2017.8 · Cited by 11
Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 15
Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors
Yang, J., Hu, J., Zhang, G., Li, Q., Wen, H., & Tang, Y. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04881-3 · Cited by 10
Can α-synuclein be targeted in novel therapies for Parkinson’s disease?
Brundin, P., & Olsson, R. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.73 · Cited by 10
Self-citationImaging Protein Oligomerization in Neurodegeneration Using Bimolecular Fluorescence Complementation
Herrera, F., Gonçalves, S. A., & Outeiro, T. F. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391856-7.00033-0 · Cited by 10
Self-citationLa maladie de Parkinson est-elle une maladie à prion ?
Brandel, J., Corbillé, A.-G., Derkinderen, P., & Haı̈k, S. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.005 · Cited by 13
Nanoparticle and Stem Cell Combination Therapy for the Management of Stroke
Salatin, S., Farhoudi, M., Sadigh‐Eteghad, S., & Farjami, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221213113119 · Cited by 9
Gima, S., Oe, K., Nishimura, K., Ohgita, T., Ito, H., Kimura, H., Saito, H., & Takata, K. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.019 · Cited by 9
Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach
Coles, N. P., Elsheikh, S., Quesnel, A., Butler, L., Jennings, C., Tarzi, C., Achadu, O. J., Islam, M., Kalesh, K., Occhipinti, A., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00726 · Cited by 9
Self-citationOpportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
Westwood, M., & Lawson, A. D. G. (2015) · Antibodies · doi:10.3390/antib4030170 · Cited by 9
The “somatic-spread” hypothesis for sporadic neurodegenerative diseases
Pamphlett, R. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.027 · Cited by 9
Aspects on the integrative actions of the brain from neural networks to “brain-body medicine”
Agnati, L. F., Guidolin, D., Guescini, M., Battistin, L., Stocchi, V., De, R., Genedani, S., & Fuxé, K. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.687748 · Cited by 9
Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
Yoshida, S., & Hasegawa, T. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105307 · Cited by 9
Anti-amyloidogenic effect of artemin on α -synuclein
Marvastizadeh, N., Dabirmanesh, B., Sajedi, R. H., & Khajeh, K. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0446 · Cited by 9
Synuclein and Parkinson’s Disease: An Update
Jellinger, K. A. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737357-00175 · Cited by 9
Zhong, Z., Li, J., Zhong, J., Huang, Y., Hu, J., Zhang, P., Zhang, B., Jin, Y., Luo, W., Liu, R., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00479-z · Cited by 8
Self-citationUric acid regulates α-synuclein transmission in Parkinsonian models
Shin, Y. J., Kim, Y. J., Lee, J. E., Kim, Y. S., Lee, J. W., Kim, H.-J., Shin, J. Y., & Lee, P. H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1117491 · Cited by 8
Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy
Craig, C. F., Finkelstein, D. I., McQuade, R. M., & Diwakarla, S. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106296 · Cited by 8
Rockenstein, E. M., Desplats, P., Ubhi, K. K., Mante, M., Florio, J. B., Adame, A., Winter, S., Brandstaetter, H., Meier, D., Moessler, H., et al. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25521 · Cited by 8
Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells
Nandakumar, S., Vijayan, B., Kishore, A., & Thekkuveettil, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0402-x · Cited by 9
The Molecular Physiopathogenesis of Islet Amyloidosis
Bhowmick, D. C., Singh, S., Trikha, S., & Jeremic, A. M. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_62 · Cited by 8
Wu, Z., Gao, J., Du, T., Tang, D., Chen, N., Yuan, Y., & Ma, K. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.12.008 · Cited by 8
Extracellular vesicles in neurodegenerative disorders
Mäger, I., Willms, E., Bonner, S. E., Hill, A. F., & Wood, M. J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00012-2 · Cited by 8
A colonic biomarker of Parkinson's disease?
Olanow, C. W. (2012) · Movement Disorders · doi:10.1002/mds.25067 · Cited by 8
Leem, Y., Park, J., Park, J., Kim, D., Park, J.-M., Kim, S., Kang, J. L., & Kim, H.-S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117871 · Cited by 7
Sheng, Y.-C., Huang, J., Wu, W.-L., Wan, X., Wang, J., Qin, Z., & Wang, Y. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177430 · Cited by 8
Sato, H., Kato, T., & Arawaka, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8858-7 · Cited by 7
Keem, J. O., Lee, I. H., Kim, S. Y., Jung, Y., & Chung, B. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.029 · Cited by 7
Exosomes: Potential Therapies for Disease via Regulating TLRs
Guo, H., Cheng, A., Wang, M., Yin, Z., & Jia, R. (2020) · Mediators of Inflammation · doi:10.1155/2020/2319616 · Cited by 7
Poortvliet, P. C., O’Maley, K. A., Silburn, P. A., & Mellick, G. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00686 · Cited by 7
Lashuel, H. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15275 · Cited by 7
Nigral MRI features of asymptomatic welders
Lee, E.-Y., Flynn, M. R., Du, G., Lewis, M. M., Goldenberg, M. D. F., Kong, L., Mailman, R. B., Hong, Y., & Huang, X. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.02.020 · Cited by 7
Etiology and pathogenesis of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 8
Alpha Synuclein and Parkinson’s Disease
Parihar, A., Parihar, P., Solanki, I., & Parihar, M. S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_1 · Cited by 8
Reaping what you sow: Cross‐seeding between aggregation‐prone proteins in neurodegeneration
Yacoubian, T. A., & Standaert, D. G. (2014) · Movement Disorders · doi:10.1002/mds.25766 · Cited by 7
Edwards, S., Corrigan, F., & Collins‐Praino, L. E. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04706-x · Cited by 8
Grass, L., Grimaldi, S., & Damier, P. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.06.012 · Cited by 6
Bouvier‐Müller, A., Fourmy, D., Fenyi, A., Bousset, L., Melki, R., & Ducongè, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae544 · Cited by 6
Self-citationSo, R. W. L., Amano, G., Stuart, E., Amini, A. E., Aguzzi, A., Collingridge, G. L., & Watts, J. C. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012517 · Cited by 6
Gribaudo, S., Bousset, L., Courte, J., Melki, R., Peyrin, J., & Perrier, A. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_24 · Cited by 6
Self-citationDoes a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?
Sacino, A. N., & Giasson, B. I. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt151 · Cited by 6
Minello, A., & Dalla‐Zuanna, G. (2019) · European Journal of Criminology · doi:10.1177/1477370819884251 · Cited by 6
A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrils
Jarvela, T. S., Chaplot, K., & Lindberg, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0241161 · Cited by 6
Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
Ganguly, U., Singh, S., Chakrabarti, S., Saini, A. K., & Saini, R. V. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.010 · Cited by 6
Li, J., Luo, H., Zheng, H., Duan, S., Zhao, T., Yuan, Y., Liu, Y., Zhang, X., Wang, Y., Yang, J., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.975619 · Cited by 5
Self-citationCardiac electrical remodeling and neurodegenerative diseases association
Joviano‐Santos, J. V., Santos‐Miranda, A., & Roman‐Campos, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118976 · Cited by 5
Magal, P., Noussair, A., Pasquier, J., Zongo, P., & Foll, F. L. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0319-9 · Cited by 5
A new model to study cell-to-cell transfer of αSynuclein in vivo
Mercado, G., López, N., Martinez, A. N., Sardi, S. P., & Hetz, C. A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.053 · Cited by 5
Jellinger, K. A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1638908 · Cited by 6
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
The Lysosome in Aging‐Related Neurodegenerative Diseases
Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch9 · Cited by 5
Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease
Srivastava, A., Kataria, A., Yadav, D. K., Han, I., & Choi, E. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00003-9 · Cited by 4
Robinson, E. C., Gorecki, A. M., Pesce, S. R., Bagda, V., Anderton, R. S., & Meloni, B. P. (2025) · Biomedicines · doi:10.3390/biomedicines13010122 · Cited by 4
Effects of exogenous alpha-synuclein on stimulated dopamine overflow in dorsal striatum
Pelkonen, A., Kallunki, P., & Yavich, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.072 · Cited by 4
Self-citationBitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 4
Ben-David, E., & Tu, R. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4092 · Cited by 4
Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease
Bailey, L. J., Elson, J. L., & Pienaar, I. S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1270-5_19 · Cited by 4
Rahul, R., & Siddique, Y. H. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210903101841 · Cited by 5
Regensburger, M., Schreglmann, S. R., Stoll, S., Rockenstein, E. M., Loskarn, S., Xiang, W., Masliah, E., & Winner, B. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1561-5 · Cited by 5
Yamamoto, K. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01334-6 · Cited by 4
Hybridization of amantadine with gardenamide A enhances NMDA antagonism and in vivo anti-PD effects
Zhu, W., Fan, Y., Li, Y., Peng, L., Li, Y.-F., Yan, F., Zhao, J., Zhang, L., Kurihara, H., He, R., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106223 · Cited by 4
Guseo, A. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29461 · Cited by 5
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
Ferrari, E. S., Salvadè, M., Zianni, E., Brumana, M., Luca, M. D., & Gardoni, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1152065 · Cited by 4
Raina, A., Wang, W., Gonzalez, J., Yan, X. E., Overstreet‐Wadiche, L., Wadiche, J. I., Zhang, C., & Chen, S. G. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111005 · Cited by 3
Al‐Lahham, R., Corkins, M. E., Ishtikhar, M., Rabadia, P., Ramírez, S., Banerjee, V., & Shahnawaz, M. (2025) · Cells · doi:10.3390/cells14100684 · Cited by 3
Measurement of α-Synuclein Dynamics In Vivo Using Microdialysis with a Novel Homogeneous Immunoassay
Kim, Y., Geng, L., Lenhart, A. E., Li, J., Dauer, W. T., & Kennedy, R. T. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00251 · Cited by 3
Self-citationThe direct transfer approach for transcellular drug delivery
Wang, Y.-F., Shen, Z.-F., Xiang, F., Wang, H., Zhang, P., & Zhang, Q. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2288799 · Cited by 3
Revisiting the advance of age-dependent α-synuclein propagation and aggregation
Song, D., & Li, J. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.44 · Cited by 4
Self-citationThe gut microbiome as a factor in the development of Parkinson's disease
Арамайисовна, Б. Л., Poluektova, E. A., & Poluektov, M. G. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-1-90-96 · Cited by 3
Tokunbo, O. S., Arogundade, T. T., Abayomi, T. A., Lewu, F. S., Abayomi, O. A., Obembe, O. O., Bayo-Olugbami, A. A., Ilesanmi, D., Keji, S. T., & Enaibe, B. U. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102271 · Cited by 3
Chandrababu, K., Radhakrishnan, V., Anjana, A. S., Rajan, R. S., Sivan, U., Krishnan, S., & Chakrapani, P. S. B. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06735-1 · Cited by 3
Update on Idiopathic Parkinson’s disease
Pupo, J. M. R., Rojas, Y. V. D., Rodríguez, Y. R., Rodríguez, Y. R., & Rodríguez, R. A. (2013) · Correo Científico Médico · Cited by 3
The multitude of therapeutic targets in neurodegenerative proteinopathies
Melki, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00001-4 · Cited by 3
Self-citationJellinger, K. A., & Krismer, F. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0687-7_4 · Cited by 3
Bentea, L., Ölveczky, P. C., & Bentea, E. (2013) · Lecture notes in computer science · doi:10.1007/978-3-642-40708-6_8 · Cited by 3
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 3
Self-citationDeciphering the Seed Size-Dependent Cellular Internalization Mechanism for α-Synuclein Fibrils
Sakunthala, A., & Maji, S. K. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00667 · Cited by 2
Lungu, R., Fernandes, F. F., Monteiro, S. P., Outeiro, T. F., & Shemesh, N. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251338952 · Cited by 2
Self-citationZetterdahl, O. G., Crowe, J. A., Reyhani, S., Güra, M. A., Labastida-Botey, O., Girard, A. S., Froese, D. S., Ahlenius, H., & Canals, I. (2025) · eNeuro · doi:10.1523/eneuro.0093-25.2025 · Cited by 2
Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects
Dong, S., Lu, J., Wu, L., Wang, S., 宫玉波, Hu, J., Liu, Y., & Chen, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116780 · Cited by 2
Propriétés infectieuses des agrégats de protéines impliquées dans des maladies neurodégénératives
Bousset, L., & Melki, R. (2013) · Biologie Aujourd hui · doi:10.1051/jbio/2013004 · Cited by 2
Self-citationBrundin, P., & Coetzee, G. A. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14333 · Cited by 2
Self-citationThe role of alpha-sinuclein in the neurodegenerative process
Sobolev, V. B., & Худоерков, Р. М. (2019) · CLINICAL AND EXPERIMENTAL MORPHOLOGY · doi:10.31088/cem2019.8.3.5-12 · Cited by 2
Patrigeon, M., Brot, S., Bonnet, M., Belnoue, L., & Gaillard, A. (2023) · Transplantation · doi:10.1097/tp.0000000000004565 · Cited by 2
The Prion-Like Aspect of Alzheimer Pathology
Fritschi, S. K., Eftekharzadeh, B., Manfredi, G., Hamaguchi, T., Heilbronner, G., Nagarathinam, A., Langer, F., Eisele, Y. S., Walker, L. C., & Jucker, M. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_5 · Cited by 2
Brooks, P. L., Visanji, N. P., Hazrati, L., & Lang, A. E. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.05.004 · Cited by 2
Cell therapy for Parkinson’s disease
Morizane, A., & Takahashi, J. B. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.147.264 · Cited by 2
Methods and Protocols for Developing Prion Vaccines
Marciniuk, K., Taschuk, R., & Napper, S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_37 · Cited by 2
Mechanisms for cell‐to‐cell propagation no longer lag behind
Kordower, J. H., & Brundin, P. (2016) · Movement Disorders · doi:10.1002/mds.26879 · Cited by 2
Self-citationBajić, V., Salhi, A., Lakota, K., Radovanović, A., Razali, R., Živković, L., Spremo‐Potparević, B., Uludağ, M., Tifratene, F., Motwalli, O., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271737 · Cited by 2
Metadata
- Authors
- Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., Li, J.-Y., & Brundin, P.
- Affiliations
- Lund University (SE)
- Lundbeck (Denmark) (DK)
- Laboratoire d'Enzymologie et Biochimie Structurales (FR)
- University of Lisbon (PT)
- Corresponding author
- Brundin, Patrik
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-02-01
- Volume
- 121
- Issue
- 2
- Pages
- 715-725
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3026723
- OpenAlex
- W2046885195
- Cited by
- 842
- References
- 42
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 43 · 2021: 69 · 2020: 70 · 2019: 59 · 2018: 51 · 2017: 72 · 2016: 68 · 2015: 68 · 2014: 64 · 2013: 77 · 2012: 64
- FWCI
- 50.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- Agence Nationale de la Recherche
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Stiftelsen Lars Hiertas Minne
- Centre National de la Recherche Scientifique
- Parkinsonfonden
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, Parkinson's disease, Lewy bodies, intercellular transfer, endocytosis, neuroblastoma cells, intracortical injection
- MeSH terms
- Animals, Brain, Cells, Cultured, Dopamine, Humans, Neurons, Parkinson Disease, Recombinant Fusion Proteins, Lewy Bodies, Culture Media, Conditioned, Cell Transplantation, Coculture Techniques, Mice, Rats, alpha-Synuclein, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
